Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

SELL
$1.09 - $1.9 $3,605 - $6,285
-3,308 Reduced 3.18%
100,817 $119,000
Q2 2024

Aug 14, 2024

SELL
$1.09 - $1.9 $3,605 - $6,285
-3,308 Reduced 3.18%
100,817 $119,000
Q1 2024

Oct 17, 2024

BUY
$1.4 - $2.55 $4,631 - $8,435
3,308 Added 3.28%
104,125 $159,000
Q1 2024

Aug 16, 2024

BUY
$1.4 - $2.55 $23,604 - $42,993
16,860 Added 19.32%
104,125 $159,000
Q1 2024

May 15, 2024

BUY
$1.4 - $2.55 $23,604 - $42,993
16,860 Added 19.32%
104,125 $159,000
Q4 2023

Aug 16, 2024

SELL
$1.0 - $3.39 $13,552 - $45,941
-13,552 Reduced 13.44%
87,265 $150,000
Q4 2023

Feb 13, 2024

BUY
$1.0 - $3.39 $30,691 - $104,042
30,691 Added 54.25%
87,265 $150,000
Q3 2023

Nov 15, 2023

BUY
$2.6 - $4.23 $97,258 - $158,231
37,407 Added 195.16%
56,574 $185,000
Q2 2023

Aug 14, 2023

SELL
$3.2 - $4.33 $51,110 - $69,158
-15,972 Reduced 45.45%
19,167 $76,000
Q1 2023

May 15, 2023

SELL
$3.79 - $6.22 $19,427 - $31,883
-5,126 Reduced 12.73%
35,139 $144,000
Q4 2022

Feb 14, 2023

SELL
$3.53 - $5.49 $14,056 - $21,861
-3,982 Reduced 9.0%
40,265 $172,000
Q3 2022

Nov 14, 2022

BUY
$3.74 - $7.09 $69,193 - $131,172
18,501 Added 71.86%
44,247 $204,000
Q2 2022

Oct 27, 2022

BUY
$4.33 - $7.45 $4,871 - $8,381
1,125 Added 4.57%
25,746 $159,000
Q2 2022

Aug 15, 2022

BUY
$4.33 - $7.45 $4,871 - $8,381
1,125 Added 4.57%
25,746 $159,000
Q1 2022

Oct 27, 2022

SELL
$5.84 - $13.61 $6,570 - $15,311
-1,125 Reduced 4.37%
24,621 $144,000
Q1 2022

May 13, 2022

SELL
$5.84 - $13.61 $239,825 - $558,908
-41,066 Reduced 62.52%
24,621 $144,000
Q4 2021

Feb 14, 2022

BUY
$12.52 - $19.02 $474,783 - $721,276
37,922 Added 136.58%
65,687 $853,000
Q3 2021

Nov 15, 2021

BUY
$10.47 - $20.87 $290,699 - $579,455
27,765 New
27,765 $379,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $17.2M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.